Abstract
In the last chapter, Das and Das have presented the advantages of biodegradable polymeric nanoparticles in biomedical use, and have also provided an overview of general methods of fabricating and designing nanoparticles. In this chapter, we will continue to talk about nanoparticles as carriers of therapeutics, but will narrow down the focus of the discussions to the context of neurological aging. In fact, neurological disorders such as Parkinson’s disease, Alzheimer’s diseases, neuropathic pain, and cerebrovascular accidents affect approximately 1.5 billion people globally. Over the years, an array of bioactive molecules have been found to be effective for the treatment of neurological conditions but not to be clinically effective due to the presence of the blood–brain barrier (BBB). The BBB is primarily responsible for the separation of extracellular fluid and blood within the CNS, generating a selectively permeable barrier restricting the passage of an array of substances, such as drugs, biomolecules, and potentially pathogenic substances. Nanomedicine is an attractive non-invasive technology that can be employed to circumvent this barrier. In this chapter, we will review the current advancements and limitations for the employment of nanomedicine to treat neurological diseases, and will also delineate the clinical and regulatory requirement for market entry of these products.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdou EM, Kandil SM, El Miniawy HM (2017) Brain targeting efficiency of antimigrain drug loaded mucoadhesive intranasal nanoemulsion. Int J Pharm 529(1–2):667–677
Agrawal P, Singh RP, Sharma G, Mehata AK, Singh S, Rajesh CV, Pandey BL, Koch B, Muthu MS (2017) Bioadhesive micelles of d-α-tocopherol polyethylene glycol succinate 1000: Synergism of chitosan and transferrin in targeted drug delivery. Colloids Surf, B 152:277–288
Ai H, Wang F, Xia Y, Chen X, Lei C (2012) Antioxidant, antifungal and antiviral activities of chitosan from the larvae of housefly Musca domestica L.. Food Chem 132(1):493–498
Ajetunmobi A, Prina-Mello A, Volkov Y, Corvin A, Tropea D (2014) Nanotechnologies for the study of the central nervous system. Prog Neurobiol 123:18–36
Albert SM (2007) Projecting neurologic disease burden: difficult but critical. Neurology 68(5):322–323
Alexis F, Pridgen E, Molnar LK, Farokhzad OC (2008) Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5(4):505–515
Allison SD (2008) Effect of structural relaxation on the preparation and drug release behavior of poly(lactic-co-glycolic) acid microparticle drug delivery systems. J Pharm Sci 97(6):2022–2035
Anselmo AC, Mitragotri S (2017) Impact of particle elasticity on particle-based drug delivery systems. Adv Drug Deliv Rev 108:51–67
Aspden TJ, Illum L, Skaugrud Ø (1996) Chitosan as a nasal delivery system: evaluation of insulin absorption enhancement and effect on nasal membrane integrity using rat models. Eur J Pharm Sci 4(1):23–31
Barenholz YC (2012) Doxil®—the first FDA-approved nano-drug: lessons learned. J Control Release 160(2):117–134
Bhatta RS, Chandasana H, Chhonker YS, Rathi C, Kumar D, Mitra K, Shukla PK (2012) Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies. Int J Pharm 432(1–2):105–112
Biliuta G, Coseri S (2019) Cellulose: A ubiquitous platform for ecofriendly metal nanoparticles preparation. Coord Chem Rev 383:155–173
Boche M, Pokharkar V (2017) Quetiapine nanoemulsion for intranasal drug delivery: evaluation of brain-targeting efficiency. AAPS PharmSciTech 18(3):686–696
Brannon-Peppas L, Blanchette JO (2004) Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 56(11):1649–1659
Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith SC Jr, Tager I (2004) Air pollution and cardiovascular disease: a statement for healthcare professionals from the expert panel on population and prevention science of the American heart association. Circulation 109(21):2655–2671
Carradori D, Gaudin A, Brambilla D, Andrieux K (2016) Application of nanomedicine to the CNS diseases. Int Rev Neurobiol 130:73–113
Charoensit P, Pompimon W, Khorana N, Sungthongjeen S (2019) Effect of amide linkage of PEG-lipid conjugates on the stability and cytotoxic activity of goniodiol loaded in PEGylated liposomes. J Drug Deliv Sci Technol 50:1–8
Chen X, Kis A, Zettl A, Bertozzi CR (2007) A cell nanoinjector based on carbon nanotubes. Proc Natl Acad Sci 104(20):8218–8222
Christoper GP, Raghavan CV, Siddharth K, Kumar MS, Prasad RH (2014) Formulation and optimization of coated PLGA–Zidovudine nanoparticles using factorial design and in vitro in vivo evaluations to determine brain targeting efficiency. Saudi Pharm J 22(2):133–140
Daneman R, Zhou L, Kebede AA, Barres BA (2010) Pericytes are required for blood–brain barrier integrity during embryogenesis. Nature 468(7323):562
Das S, Carnicer-Lombarte A, Fawcett JW, Bora U (2016) Bio-inspired nano tools for neuroscience. Prog Neurobiol 142:1–22
De Jong WH, Borm PJ (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3(2):133
De Luca MA, Lai F, Corrias F, Caboni P, Bimpisidis Z, Maccioni E, Fadda AM, Di Chiara G (2015) Lactoferrin-and antitransferrin-modified liposomes for brain targeting of the NK3 receptor agonist senktide: preparation and in vivo evaluation. Int J Pharm 479(1):129–137
Desai N (2012) Challenges in development of nanoparticle-based therapeutics. AAPS J 14(2):282–295
Ding D, Zhu Q (2018) Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics. Mater Sci Eng, C 92:1041–1060
Dobrovolskaia MA, McNeil SE (2013) Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. J Control Release 172(2):456–466
Donati I, Holtan S, Mørch YA, Borgogna M, Dentini M, Skjåk-Bræk G (2005) New hypothesis on the role of alternating sequences in calcium-alginate gels. Biomacromolecules 6(2):1031–1040
Đorđević SM, Santrač A, Cekić ND, Marković BD, Divović B, Ilić TM, Savić MM, Savić SD (2017) Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: physicochemical and in vivo performances. Int J Pharm 533(2):421–430
Du X, Yin S, Xu L, Ma J, Yu H, Wang G, Li J (2019) Polylysine and cysteine functionalized chitosan nanoparticle as an efficient platform for oral delivery of paclitaxel. Carbohydr Polym 115484
Duncan R, Izzo L (2005) Dendrimer biocompatibility and toxicity. Adv Drug Deliv Rev 57(15):2215–2237
Duncan R, Gaspar R (2011) Nanomedicine (s) under the microscope. Mol Pharm 8(6):2101–2141
Elhissi A, Ahmed W, Dhanak V, Subramani K (2012) Carbon nanotubes in cancer therapy and drug delivery. In: Subramani K, Ahmed W (eds) Emerging nanotechnologies in dentistry. William Andrew Publishing, US, pp 347–363
Fornaguera C, Dols-Perez A, Caldero G, Garcia-Celma MJ, Camarasa J, Solans C (2015) PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood–brain barrier. J Control Release 211:134–143
Furtado D, Björnmalm M, Ayton S, Bush AI, Kempe K, Caruso F (2018) Overcoming the blood–brain barrier: the role of nanomaterials in treating neurological diseases. Adv Mater 30(46):1801362
García-González CA, Alnaief M, Smirnova I (2011) Polysaccharide-based aerogels—promising biodegradable carriers for drug delivery systems. Carbohydr Polym 86(4):1425–1438
Gaspar R (2010) Therapeutic products: regulating drugs and medical devices. Edward Elgar Publishing, UK
Gaspar RS, Florindo HF, Silva LC, Videira MA, Corvo ML, Martins BF, Silva-Lima B (2014) Regulatory aspects of oncologicals: nanosystems main challenges. In: Alonso MJ, Garcia-Fuentes M (eds) Nano-oncologicals. Springer, US, pp 425–452
Gentile F, Chiappini C, Fine D, Bhavane RC, Peluccio MS, Cheng MM, Liu X, Ferrari M, Decuzzi P (2008) The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows. J Biomech 41(10):2312–2318
Gruškienė R, Deveikytė R, Makuška R (2013) Quaternization of chitosan and partial destruction of the quaternized derivatives making them suitable for electrospinning. Chemija 24(4):325–334
Guo Q, You H, Yang X, Lin B, Zhu Z, Lu Z, Li X, Zhao Y, Mao L, Shen S, Cheng H (2017) Functional single-walled carbon nanotubes ‘CAR’for targeting dopamine delivery into the brain of parkinsonian mice. Nanoscale 9(30):10832–10845
Gupta A, Eral HB, Hatton TA, Doyle PS (2016) Nanoemulsions: formation, properties and applications. Soft Matter 12(11):2826–2841
Harris JM (1992) Introduction to biotechnical and biomedical applications of poly (ethylene glycol). In: Harris JM (ed) Poly (ethylene glycol) chemistry. Springer, Boston, pp 1–14
He P, Davis SS, Illum L (1998) In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm 166(1):75–88
Holban AM, Grumezescu AM, Andronescu E (2016) Inorganic nanoarchitectonics designed for drug delivery and anti-infective surfaces. In: Grumezescu AM (ed) Surface chemistry of nanobiomaterials. William Andrew Publishing, US, pp 301–327
Hwang SR, Kim K (2014) Nano-enabled delivery systems across the blood–brain barrier. Arch Pharmacal Res 37(1):24–30
Iyer AK, Khaled G, Fang J, Maeda H (2006) Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Disc Today 11(17–18):812–818
Jafarieh O, Md S, Ali M, Baboota S, Sahni JK, Kumari B, Bhatnagar A, Ali J (2015) Design, characterization, and evaluation of intranasal delivery of ropinirole-loaded mucoadhesive nanoparticles for brain targeting. Drug Dev Ind Pharm 41(10):1674–1681
Jain A, Jain A, Garg NK, Tyagi RK, Singh B, Katare OP, Webster TJ, Soni V (2015) Surface engineered polymeric nanocarriers mediate the delivery of transferrin–methotrexate conjugates for an improved understanding of brain cancer. Acta Biomater 24:140–151
Joshi S, Singh-Moon RP, Ellis JA, Chaudhuri DB, Wang M, Reif R, Bruce JN, Bigio IJ, Straubinger RM (2014a) Cerebral hypoperfusion-assisted intra-arterial deposition of liposomes in normal and glioma-bearing rats. Neurosurgery 76(1):92–100
Joshi S, Singh-Moon R, Wang M, Chaudhuri DB, Ellis JA, Bruce JN, Bigio IJ, Straubinger RM (2014b) Cationic surface charge enhances early regional deposition of liposomes after intracarotid injection. J Neurooncol 120(3):489–497
Kabanov AV, Vinogradov SV (2009) Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew Chem Int Ed 48(30):5418–5429
Kanazawa T, Kaneko M, Niide T, Akiyama F, Kakizaki S, Ibaraki H, Shiraishi S, Takashima Y, Suzuki T, Seta Y (2017) Enhancement of nose-to-brain delivery of hydrophilic macromolecules with stearate-or polyethylene glycol-modified arginine-rich peptide. Int J Pharm 530(1–2):195–200
Katare YK, Daya RP, Sookram Gray C, Luckham RE, Bhandari J, Chauhan AS, Mishra RK (2015) Brain targeting of a water insoluble antipsychotic drug haloperidol via the intranasal route using PAMAM dendrimer. Mol Pharm 12(9):3380–3388
Kauscher U, Holme MN, Björnmalm M, Stevens MM (2019) Physical stimuli-responsive vesicles in drug delivery: beyond liposomes and polymersomes. Adv Drug Deliv Rev 138:259–275
Kaushik A, Jayant RD, Sagar V, Nair M (2014) The potential of magneto-electric nanocarriers for drug delivery. Exp Opin Drug Deliv 11(10):1635–1646
Kaushik A, Jayant RD, Nair M (2016) Advancements in nano-enabled therapeutics for neuroHIV management. Int J Nanomed 11:4317
Kendra DF, Hadwiger LA (1984) Characterization of the smallest chitosan oligomer that is maximally antifungal to Fusarium solani and elicits pisatin formation in Pisum sativum. Exp Mycol 8(3):276–281
Klibanov AL, Maruyama K, Torchilin VP, Huang L (1990) Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268(1):235–237
Kumar M, Sharma P, Maheshwari R, Tekade M, Shrivastava SK, Tekade RK (2018) Beyond the blood–brain barrier: facing new challenges and prospects of nanotechnology-mediated targeted delivery to the brain. In: Kesharwani P, Gupta U (eds) Nanotechnology-based targeted drug delivery systems for brain tumors. Academic Press, US, pp 397–437
Lee SY, Ferrari M, Decuzzi P (2009) Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows. Nanotechnology 20(49):495101
Li Q, Liu CG, Huang ZH, Xue FF (2011) Preparation and characterization of nanoparticles based on hydrophobic alginate derivative as carriers for sustained release of vitamin D3. J Agric Food Chem 59(5):1962–1967
Lin CC, Anseth KS (2009) PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm Res 26(3):631–643
Liu Y, Tan J, Thomas A, Ou-Yang D, Muzykantov VR (2012) The shape of things to come: importance of design in nanotechnology for drug delivery. Therap Deliv 3(2):181–194
Liu Y, Ran R, Chen J, Kuang Q, Tang J, Mei L, Zhang Q, Gao H, Zhang Z, He Q (2014) Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Biomaterials 35(17):4835–4847
Ljubimova JY, Sun T, Mashouf L, Ljubimov AV, Israel LL, Ljubimov VA, Falahatian V, Holler E (2017) Covalent nano delivery systems for selective imaging and treatment of brain tumors. Adv Drug Deliv Rev 113:177–200
Maeda H (2001) The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. Adv Enzyme Regul 41:189–207
Makadia HK, Siegel SJ (2011) Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers 3(3):1377–1397
Martínez-Sanz M, Lopez-Rubio A, Lagaron JM (2011a) Optimization of the nanofabrication by acid hydrolysis of bacterial cellulose nanowhiskers. Carbohydr Polym 85(1):228–236
Martínez-Sanz M, Olsson RT, Lopez-Rubio A, Lagaron JM (2011b) Development of electrospun EVOH fibres reinforced with bacterial cellulose nanowhiskers. Part I: Characterization and method optimization. Cellulose 18(2):335–347
Merkel TJ, Jones SW, Herlihy KP, Kersey FR, Shields AR, Napier M, Luft JC, Wu H, Zamboni WC, Wang AZ, Bear JE (2011) Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proc Natl Acad Sci 108(2):586–591
Mir M, Ahmed N, ur Rehman A (2017) Recent applications of PLGA based nanostructures in drug delivery. Colloids Surf B: Biointerf 159:217–231
Molineux G (2002) Pegylation: engineering improved pharmaceuticals for enhanced therapy. Cancer Treat Rev 28:13–16
Muthu MS (2014) Nanoparticles based on PLGA and its co-polymer: an overview. Asian J Pharm 3(4):266–273
Muthu MS, Leong DT, Mei L, Feng SS (2014) Nanotheranostics˗application and further development of nanomedicine strategies for advanced theranostics. Theranostics 4(6):660
Nagpal K, Singh SK, Mishra DN (2013) Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety. Int J Biol Macromol 59:72–83
Nair M, Jayant RD, Kaushik A, Sagar V (2016) Getting into the brain: potential of nanotechnology in the management of NeuroAIDS. Adv Drug Deliv Rev 103:202–217
Narum SM, Le T, Le DP, Lee JC, Donahue ND, Yang W, Wilhelm S (2020) Passive targeting in nanomedicine: fundamental concepts, body interactions, and clinical potential. In: Chung EJ, Leon L, Rinaldi C (eds) Nanoparticles for biomedical applications. Elsevier, The Netherlands, pp 37–53
Niaz T, Nasir H, Shabbir S, Rehman A, Imran M (2016) Polyionic hybrid nano-engineered systems comprising alginate and chitosan for antihypertensive therapeutics. Int J Biol Macromol 91:180–187
Olson F, Hunt CA, Szoka FC, Vail WJ, Papahadjopoulos D (1979) Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim Biophys Acta (BBA)-Biomembr 557(1):9–23
Owens DE III, Peppas NA (2006) Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307(1):93–102
Patel HK, Gajbhiye V, Kesharwani P, Jain NK (2016) Ligand anchored poly (propyleneimine) dendrimers for brain targeting: comparative in vitro and in vivo assessment. J Colloid Interface Sci 482:142–150
Pautler M, Brenner S (2010) Nanomedicine: promises and challenges for the future of public health. Int J Nanomed 5:803
Peluffo H, Unzueta U, Negro-Demontel ML, Xu Z, Váquez E, Ferrer-Miralles N, Villaverde A (2015) BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS. Biotechnol Adv 33(2):277–287
Peppas NA, Keys KB, Torres-Lugo M, Lowman AM (1999) Poly (ethylene glycol)-containing hydrogels in drug delivery. J Control Release 62(1–2):81–87
Qazanfarzadeh Z, Kadivar M (2016) Properties of whey protein isolate nanocomposite films reinforced with nanocellulose isolated from oat husk. Int J Biol Macromol 91:1134–1140
Qi L, Xu Z, Jiang X, Hu C, Zou X (2004) Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res 339(16):2693–2700
Rashed HM, Shamma RN, Basalious EB (2017) Contribution of both olfactory and systemic pathways for brain targeting of nimodipine-loaded lipo-pluronics micelles: in vitro characterization and in vivo biodistribution study after intranasal and intravenous delivery. Drug Deliv 24(1):181–187
Reynolds JL, Mahato RI (2017) Nanomedicines for the treatment of CNS diseases. J Neuroimmune Pharmacol 12(1):1–5
Rondeau E, Cooper-White JJ (2008) Biopolymer microparticle and nanoparticle formation within a microfluidic device. Langmuir 24(13):6937–6945
Rudzinski WE, Aminabhavi TM (2010) Chitosan as a carrier for targeted delivery of small interfering RNA. Int J Pharm 399(1–2):1–1
Sainz V, Conniot J, Matos AI, Peres C, Zupanǒiǒ E, Moura L, Silva LC, Florindo HF, Gaspar RS (2015) Regulatory aspects on nanomedicines. Biochem Biophys Res Commun 468(3):504–510
Sanvicens N, Marco MP (2008) Multifunctional nanoparticles–properties and prospects for their use in human medicine. Trends Biotechnol 26(8):425–433
Shah S (2016) The nanomaterial toolkit for neuroengineering. Nano Conv 3(1):25
Sharma D, Sharma N, Pathak M, Agrawala PK, Basu M, Ojha H (2018) Nanotechnology-based drug delivery systems: challenges and opportunities. In: Grumezescu AM (ed) Drug targeting and stimuli sensitive drug delivery systems. William Andrew Publishing, US, pp 39–79
Shen Z, Ye H, Kröger M, Li Y (2017) Self-assembled core–polyethylene glycol–lipid shell nanoparticles demonstrate high stability in shear flow. Phys Chem Chem Phys 19(20):13294–13306
Shen Z, Fisher A, Liu WK, Li Y (2018) PEGylated “stealth” nanoparticles and liposomes. In: Parambath A (ed) Engineering of biomaterials for drug delivery systems. Woodhead Publishing, US, pp 1–26
Shen ZQ, Loe DT, Awino JK, Kroger M, Rouge JL, Li Y (2016) Self-assembly of core-polyethylene glycol-lipid shell (CPLS) nanoparticles and their potential as drug delivery vehicles. Nanoscale 8(31):14821–14835
Singh P, Kim YJ, Zhang D, Yang DC (2016) Biological synthesis of nanoparticles from plants and microorganisms. Trends Biotechnol 34(7):588–599
Soni N, Tekade M, Kesharwani P, Bhattacharya P, Maheshwari R, Dua K, M Hansbro P, Kumar Tekade R (2017) Recent advances in oncological submissions of dendrimer. Curr Pharm Des 23(21):3084–3098
Soni V, Pandey V, Asati S, Jain P, Tekade RK (2019) Design and fabrication of brain-targeted drug delivery. In: Tekade RK (ed) Basic fundamentals of drug delivery. Academic Press, US, pp 539–593
Swami R, Singh I, Kulhari H, Jeengar MK, Khan W, Sistla R (2015) p-Hydroxy benzoic acid-conjugated dendrimer nanotherapeutics as potential carriers for targeted drug delivery to brain: an in vitro and in vivo evaluation. J Nanopart Res 17(6):265
Tan SF, Kirby BP, Stanslas J, Basri HB (2017) Characterisation, in-vitro and in-vivo evaluation of valproic acid-loaded nanoemulsion for improved brain bioavailability. J Pharm Pharmacol 69(11):1447–1457
Tang S, Huang Z, Zhang H, Wang Y, Hu Q, Jiang H (2014) Design and formulation of trimethylated chitosan-graft-poly (ɛ-caprolactone) nanoparticles used for gene delivery. Carbohydr Polym 101:104–112
Tavares AJ, Poon W, Zhang YN, Dai Q, Besla R, Ding D, Ouyang B, Li A, Chen J, Zheng G, Robbins C (2017) Effect of removing Kupffer cells on nanoparticle tumor delivery. Proc Natl Acad Sci 114(51):E10871–E10880
Tekade RK, Maheshwari R, Soni N, Tekade M, Chougule MB (2017) Nanotechnology for the development of nanomedicine. In: Mishra V, Kesharwani P, Amin MCIM, Iyer A (eds) Nanotechnology-based approaches for targeting and delivery of drugs and genes. Academic Press, US, pp 3–61
Tinkle S, McNeil SE, Mühlebach S, Bawa R, Borchard G, Barenholz Y, Tamarkin L, Desai N (2014) Nanomedicines: addressing the scientific and regulatory gap. Ann N Y Acad Sci 1313(1):35–56
Tong GF, Qin N, Sun LW (2017) Development and evaluation of Desvenlafaxine loaded PLGA-chitosan nanoparticles for brain delivery. Saudi Pharm J 25(6):844–851
Vashist A, Kaushik A, Ghosal A, Nikkhah-Moshaie R, Vashist A, Jayant RD, Nair M (2017) Journey of hydrogels to nanogels: a decade after. In: Vashist A, Kaushik AK, Ahmad S, Nair M (eds) Nanogels for biomedical applications. Royal Society of Chemistry, UK, pp 1–8
Vashist A, Kaushik A, Vashist A, Bala J, Nikkhah-Moshaie R, Sagar V, Nair M (2018) Nanogels as potential drug nanocarriers for CNS drug delivery. Drug Disc Today 23(7):1436–1443
Vieira DB, Gamarra LF (2016) Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier. Int J Nanomed 11:5381
Vinogradov SV (2010) Nanogels in the race for drug delivery. Nanomedicine 5(2):165–168
Vinogradov SV, Bronich TK, Kabanov AV (2002) Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Deliv Rev 54(1):135–147
Vinogradov SV, Batrakova EV, Kabanov AV (2004) Nanogels for oligonucleotide delivery to the brain. Bioconjug Chem 15(1):50–60
Vivek R, Thangam R, Nipunbabu V, Ponraj T, Kannan S (2014) Oxaliplatin-chitosan nanoparticles induced intrinsic apoptotic signaling pathway: a “smart” drug delivery system to breast cancer cell therapy. Int J Biol Macromol 65:289–297
Vogtle F, Richardt G, Werner N (2009) Dendrimer chemistry. Strauss GmbH, Morlenbach
Wagner V, Dullaart A, Bock AK, Zweck A (2006) The emerging nanomedicine landscape. Nat Biotechnol 24(10):1211
Wang Q, Jamal S, Detamore MS, Berkland C (2011) PLGA-chitosan/PLGA-alginate nanoparticle blends as biodegradable colloidal gels for seeding human umbilical cord mesenchymal stem cells. J Biomed Mater Res, Part A 96(3):520–527
Wang J, Wang M, Zheng M, Guo Q, Wang Y, Wang H, Xie X, Huang F, Gong R (2015) Folate mediated self-assembled phytosterol-alginate nanoparticles for targeted intracellular anticancer drug delivery. Colloids Surf, B 129:63–70
Xie J, Shen Z, Anraku Y, Kataoka K, Chen X (2019) Nanomaterial-based blood-brain-barrier (BBB) crossing strategies. Biomaterials 224:119491
Yan H, Chen X, Feng M, Shi Z, Zhang W, Wang Y, Ke C, Lin Q (2019) Entrapment of bacterial cellulose nanocrystals stabilized Pickering emulsions droplets in alginate beads for hydrophobic drug delivery. Colloids Surf, B 177:112–120
Yang JS, Xie YJ, He W (2011) Research progress on chemical modification of alginate: a review. Carbohydr Polym 84(1):33–39
Zhang YN, Poon W, Tavares AJ, McGilvray ID, Chan WC (2016) Nanoparticle–liver interactions: cellular uptake and hepatobiliary elimination. J Control Release 240:332–348
Zhang E, Xing R, Liu S, Qin Y, Li K, Li P (2019) Advances in chitosan-based nanoparticles for oncotherapy. Carbohydr Polym 115004
Zhao M, Hu J, Zhang L, Zhang L, Sun Y, Ma N, Chen X, Gao Z (2014) Study of amphotericin B magnetic liposomes for brain targeting. Int J Pharm 475(1–2):9–16
Zhu J (2010) Bioactive modification of poly (ethylene glycol) hydrogels for tissue engineering. Biomaterials 31(17):4639–4656
Acknowledgements
This work was financially supported by the National Research Foundation (NRF) of South Africa.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Glossary
- Bioconjugation
-
Adsorption or covalent attachment of a biomacromolecule on the outer surface of another chemical entity.
- Biodegradability
-
He capacity of a material to undergo degradation in a biological environment.
- Glass transition temperature
-
The temperature at which a polymer undergoes transition from a rubbery state to a glassy state.
- Graphene
-
A two-dimensional carbon material possessing a honeycomb lattice and Dirac-like low-energy excitations.
- Ionotropic gelation
-
A gelation process mediated by the crosslinking of polyelectrolyte molecules in the presence of multivalent counter ions.
- Mucoadhesiveness
-
The ability of a material to adhere to mucosal tissues upon administration to a biological body.
- Protein corona
-
A dynamic protein layer on the surface of a nanocarrier. Its composition changes continuously due to ongoing protein desorption and absorption.
- Quantum dots
-
Fluorescent semiconductor nanocrystals that find use in imaging applications.
- Reticuloendothelial system
-
A major component of the host defense system contributing to the clearance of particulate materials and bacteria from the bloodstream.
- Risperidone
-
A benzisoxazole derivative that has been exploited as an anti-psychotic agent.
- Surface functionalization
-
Modification of surface properties for specific purposes.
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ramiah, P., Kondiah, P.P.D., Choonara, Y.E., Toit, L.C.d., Pillay, V. (2020). Use of Nanoparticulate Systems for Tackling Neurological Aging. In: Lai, WF. (eds) Systemic Delivery Technologies in Anti-Aging Medicine: Methods and Applications. Healthy Ageing and Longevity, vol 13. Springer, Cham. https://doi.org/10.1007/978-3-030-54490-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-030-54490-4_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-54489-8
Online ISBN: 978-3-030-54490-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)